← All diseases
Cancer
Multiple myeloma
Do you want to receive a message when there is new research about Multiple myeloma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as there is new research about Multiple myeloma. View what Premium costs.
Publications and studies (2183)
- Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease. (2024/12/18) ♡
- Galectin Plasmatic Levels Reveal a Cluster Associated with Disease Aggressiveness and Kidney Damage in Multiple Myeloma Patients. (2024/12/17) ♡
- Germline predisposition in multiple myeloma. (2024/12/17) ♡
- Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma-A Pilot Study. (2024/12/14) ♡
- Multiple Myeloma: Genetic and Epigenetic Biomarkers with Clinical Potential. (2024/12/13) ♡
- Red Cell Distribution Width at Diagnosis Reflects Advanced Disease While Dynamic Changes Predict Survival at Relapse in Multiple Myeloma: A Retrospective Study. (2024/12/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Two cases of Legionnaires' disease due to Legionella cardiaca. (2024/12/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cryptococcal Pneumonia in Multiple Myeloma: A Case Report. (2024/12/11) ♡
- Increased serum B-cell maturation antigen levels evaluated with an Elecsys-based serum B-cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma. (2024/12/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Relapsed Multiple Myeloma in the Gastrointestinal Tract With Aberrant Expression of CD3: A Case Report. (2024/12/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Coexisting Thalassemia, Immune Thrombocytopenic Purpura, and Multiple Myeloma With Osteopenia: Complex Hematologic Case in an Adult Asian Male Patient. (2024/12/08) ♡
- Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in England. (2024/12/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Listeria monocytogenes and Staphylococcus aureus coinfection in a patient with multiple myeloma: Case report. (2024/12/04) ♡
- Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma. (2024/12/03) ♡
- Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study. (2024/12/02) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Consensus guidelines for the management of treatment-naïve chronic lymphocytic leukaemia in Singapore (2024). (2024/12/02) ♡
- Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies. (2024/12/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Adjuvant therapy with zinc supplementation; anti-inflammatory and anti-oxidative role in multiple myeloma patients receiving autologous hematopoietic stem cell transplantation: a randomized controlled clinical trial. (2024/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clinical Variant of Serpentine Supravenous Hyperpigmentation Following Subcutaneous Bortezomib Injection. (2024/12/01) ♡
- Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells. (2024/12/01) ♡
- Mortality Trend of Hematological Neoplasms in Babol, Northern Iran (2013-2021). (2024/12/01) ♡
- Treatment of dexamethasone and lenalidomide-resistant multiple myeloma via RAD51 degradation using PROTAC and synergistic effects with chemotherapy. (2024/12/01) ♡
- Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Refractory Multiple Myeloma. (2024/12/01) ♡
- A Comparative Study of Euthyroid and Primary Hypothyroid Patients in End Stage Renal Disease (ESRD) Undergoing Maintenance Hemodialysis (MHD) in a Tertiary Care Hospital in Salem, Tamil Nadu. (2024/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Tumor Lysis Syndrome with Venetoclax/Carfilzomib/Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Case Report. (2024/11/29) ♡
- Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes. (2024/11/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oral vancomycin induced flushing syndrome in a multiple myeloma patient: A case report and review of the literature. (2024/11/22) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The Effect of Wearable Activity Monitors and Visual Feedback on Ambulation and Fitness in Patients Undergoing Transplantation. (2024/11/19) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Injection site reaction to teclistamab in a patient with multiple myeloma. (2024/11/02) ♡
- Proteasome inhibition induces apoptosis through simultaneous inactivation of MCL-1/BCL-XL by NOXA independent of CHOP and JNK pathways. (2024/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Regulation of ubiquitin-proteasome system and its relative pathways in pancreatic adenocarcinoma. (2024/10/27) ♡
- Impact of Malnutrition on the Length of Stay for Hospitalized Chimeric Antigen Receptor T-cell (CAR-T) Therapy Patients in the United States (2020). (2024/10/25) ♡
- Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma. (2024/10/24) ♡
- Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma. (2024/10/24) ♡
- Using nominal group technique to compare patients' and clinicians' perspectives on symptoms in multiple myeloma to inform the development of a self management tool for patients with relapsed myeloma. (2024/10/21) ♡
- Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma. (2024/10/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of nutrition and gut microbiome in the progression of multiple myeloma and its precursor disease. (2024/10/14) ♡
- Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma. (2024/10/14) ♡
- Pathogenic germ line variants in a prospective multicenter cohort of patients with multiple myeloma. (2024/10/12) ♡
- Deciphering MARCH5's impact on multiple myeloma: insights into autophagy regulation and AKT-FOXO3 signaling. (2024/10/12) ♡
- 24-Hour Urine Collection and Analysis. (2024/10/06) ♡
- Solitary plasmacytoma: should new approaches in diagnosis and treatment be adopted? (2024/10/03) ♡
- Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay. (2024/10/01) ♡
- [Mechanism of Huayu Jiedu Decoction in Inhibiting Malignant Biological Characteristics of Multiple Myeloma]. (2024/10/01) ♡
- Prevalence, outcomes, and complications of vitamin D deficiency among patients with multiple myeloma: Nationwide burden of disease. (2024/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Caregiving Experience With a Young Father With Multiple Myeloma Undergoing Renal Dialysis and Autologous Stem Cell Transplantation]. (2024/10/01) ♡
- The effects of plerixafor on the hemostatic system in patients undergoing stem cell mobilization. (2024/10/01) ♡
- Dysmorphic plasma cells in multiple myeloma. (2024/10/01) ♡
- Investigation of Non-Coding RNA-Related Autophagy Alterations in Drug-Resistant Multiple Myeloma Plasma Cells. (2024/10/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system. (2024/09/21) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.